To compare the efficacy and safety of anti-TNF-alpha treatment in RA patients with and without anti-Ro antibodies, in order to detect any change in their immunological or clinical profile.

Anti-TNF-alpha treatment in rheumatoid arthritis with anti-Ro/SSA antibodies. Analysis of 17 cases among a cohort of 322 treated patients

Ceribelli, A;
2007

Abstract

To compare the efficacy and safety of anti-TNF-alpha treatment in RA patients with and without anti-Ro antibodies, in order to detect any change in their immunological or clinical profile.
Aged
Antibodies, Antinuclear
Antibodies, Monoclonal
Antirheumatic Agents
Arthritis, Rheumatoid
Autoantibodies
Cohort Studies
DNA
Etanercept
Female
Humans
Immunoglobulin G
Infliximab
Lupus Erythematosus, Systemic
Lymphoma, Non-Hodgkin
Male
Middle Aged
Prevalence
Prospective Studies
Receptors, Tumor Necrosis Factor
Risk Factors
Tumor Necrosis Factor-alpha
File in questo prodotto:
Non ci sono file associati a questo prodotto.

I documenti in IRIS sono protetti da copyright e tutti i diritti sono riservati, salvo diversa indicazione.

Utilizza questo identificativo per citare o creare un link a questo documento: https://hdl.handle.net/11699/68543
Citazioni
  • ???jsp.display-item.citation.pmc??? ND
  • Scopus 7
  • ???jsp.display-item.citation.isi??? ND
social impact